4//SEC Filing
NORTH BRIDGE VENTURE PARTNERS V-B LP 4
Accession 0000899243-22-014796
CIK 0001327273other
Filed
Apr 13, 8:00 PM ET
Accepted
Apr 14, 4:14 PM ET
Size
21.2 KB
Accession
0000899243-22-014796
Insider Transaction Report
Form 4
NBVM GP, LLC
10% Owner
Transactions
- Purchase
Common Stock
2022-04-12$4.22/sh+527,806$2,227,341→ 909,424 total(indirect: See footnote) - Purchase
Common Stock
2022-04-12$4.22/sh+1,076,851$4,544,311→ 1,855,443 total(indirect: See footnote) - Purchase
Common Stock
2022-04-12$4.22/sh+765,010$3,228,342→ 1,318,133 total(indirect: See footnote)
NORTH BRIDGE VENTURE PARTNERS V-B LP
10% Owner
Transactions
- Purchase
Common Stock
2022-04-12$4.22/sh+1,076,851$4,544,311→ 1,855,443 total(indirect: See footnote) - Purchase
Common Stock
2022-04-12$4.22/sh+765,010$3,228,342→ 1,318,133 total(indirect: See footnote) - Purchase
Common Stock
2022-04-12$4.22/sh+527,806$2,227,341→ 909,424 total(indirect: See footnote)
North Bridge Venture Partners VI L P
10% Owner
Transactions
- Purchase
Common Stock
2022-04-12$4.22/sh+765,010$3,228,342→ 1,318,133 total(indirect: See footnote) - Purchase
Common Stock
2022-04-12$4.22/sh+1,076,851$4,544,311→ 1,855,443 total(indirect: See footnote) - Purchase
Common Stock
2022-04-12$4.22/sh+527,806$2,227,341→ 909,424 total(indirect: See footnote)
DAMORE RICHARD A
10% Owner
Transactions
- Purchase
Common Stock
2022-04-12$4.22/sh+527,806$2,227,341→ 909,424 total(indirect: See footnote) - Purchase
Common Stock
2022-04-12$4.22/sh+1,076,851$4,544,311→ 1,855,443 total(indirect: See footnote) - Purchase
Common Stock
2022-04-12$4.22/sh+765,010$3,228,342→ 1,318,133 total(indirect: See footnote)
Transactions
- Purchase
Common Stock
2022-04-12$4.22/sh+1,076,851$4,544,311→ 1,855,443 total(indirect: See footnote) - Purchase
Common Stock
2022-04-12$4.22/sh+527,806$2,227,341→ 909,424 total(indirect: See footnote) - Purchase
Common Stock
2022-04-12$4.22/sh+765,010$3,228,342→ 1,318,133 total(indirect: See footnote)
Transactions
- Purchase
Common Stock
2022-04-12$4.22/sh+765,010$3,228,342→ 1,318,133 total(indirect: See footnote) - Purchase
Common Stock
2022-04-12$4.22/sh+527,806$2,227,341→ 909,424 total(indirect: See footnote) - Purchase
Common Stock
2022-04-12$4.22/sh+1,076,851$4,544,311→ 1,855,443 total(indirect: See footnote)
NORTH BRIDGE VENTURE PARTNERS V A LP
10% Owner
Transactions
- Purchase
Common Stock
2022-04-12$4.22/sh+527,806$2,227,341→ 909,424 total(indirect: See footnote) - Purchase
Common Stock
2022-04-12$4.22/sh+1,076,851$4,544,311→ 1,855,443 total(indirect: See footnote) - Purchase
Common Stock
2022-04-12$4.22/sh+765,010$3,228,342→ 1,318,133 total(indirect: See footnote)
Footnotes (4)
- [F1]The reportable securities were acquired pursuant to the Securities Purchase Agreement dated April 7, 2022 between the Issuer, North Bridge Venture Partners V-A, L.P. ("NBVP V-A"), North Bridge Venture Partners V-B, L.P. ("NBVP V-B"), North Bridge Venture Partners VI, L.P. ("NBVP VI") and certain other investors.
- [F2]The reportable securities are owned directly by NBVP V-A. North Bridge Venture Management V, L.P. ("NBVM V") is the sole general partner of NBVP V-A and North Bridge Venture Management GP, LLC ("NBVM GP") is the sole general partner of NBVM V. Each of Edward T. Anderson ("Anderson"), a member of the Issuer's board of directors, and Richard A. D'Amore ("D'Amore") are the managing members of NBVM GP and may be deemed to have shared voting and dispositive power over the shares held by NBVP V-A. Each of NBVM V, NBVM GP, Anderson and D'Amore disclaims beneficial ownership of these securities and this report shall not be deemed an admission that any one of them is the beneficial owner of such securities for purposes of Section 16 or for any other purpose, except to the extent of their respective pecuniary interests therein.
- [F3]The reportable securities are owned directly by NBVP V-B. NBVM V is the sole general partner of NBVP V-B and NBVM GP is the sole general partner of NBVM V. Each of Anderson, a member of the Issuer's board of directors, and D'Amore are the managing members of NBVM GP and may be deemed to have shared voting and dispositive power over the shares held by NBVP V-B. Each of NBVM V, NBVM GP, Anderson and D'Amore disclaims beneficial ownership of these securities and this report shall not be deemed an admission that any one of them is the beneficial owner of such securities for purposes of Section 16 or for any other purpose, except to the extent of their respective pecuniary interests therein.
- [F4]The reportable securities are owned directly by NBVP VI. North Bridge Venture Management VI, L.P. ("NBVM VI") is the sole general partner of NBVP VI and NBVM GP is the sole general partner of NBVM VI. Each of Anderson, a member of the Issuer's board of directors, and D'Amore are the managing members of NBVM GP and may be deemed to have shared voting and dispositive power over the shares held by NBVP VI. Each of NBVM VI, NBVM GP, Anderson and D'Amore disclaims beneficial ownership of these securities and this report shall not be deemed an admission that any one of them is the beneficial owner of such securities for purposes of Section 16 or for any other purpose, except to the extent of their respective pecuniary interests therein.
Documents
Issuer
Lyra Therapeutics, Inc.
CIK 0001327273
Entity typeother
Related Parties
1- filerCIK 0001138399
Filing Metadata
- Form type
- 4
- Filed
- Apr 13, 8:00 PM ET
- Accepted
- Apr 14, 4:14 PM ET
- Size
- 21.2 KB